Comprehensive assessment of metabolic syndrome among rural Bangladeshi women

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Jesmin, Subrina ^a,b   Islam, Md ^a,b   Islam, A M ^a,b   Mia, Md ^a,b   Sultana, Sayeeda ^a,b   Zaedi, Sohel ^a,b,c   Yamaguchi, Naoto ^c   Iwashima, Yoshio ^d   Hiroe, Michiaki ^a   Watanabe, Tetsu ^e  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e TOKAI UNIVERSITY   (Japan)

Author keywords

Asia; Bangladesh; Metabolic syndrome X; Rural populations; Western; Women

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BANGLADESH; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; METABOLIC SYNDROME X; MIDDLE AGED; RURAL POPULATION; SOCIAL CLASS; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; BANGLADESH; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; RURAL POPULATION; SOCIAL CLASS; YOUNG ADULT;

EID: 84855873592     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-49     Document Type: Article

References (54)

1. Age-specific prevalence of the MS defined by the IDF and national cholesterol education program: the Norwegian HUNT 2 study. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA, BMC Publ Health 2007 7 220 10.1186/1471-2458-7- 220 (Pubitemid 350042945)
2. Metabolic syndrome: a challenging health issue in highly urbanized union territory of north India. Magat C, Goel NK, Walia DK, Agawal N, Sharma MK, Kaur J, Singh R, Singh G, Diabetol Metab Syndr 2010 2 19 10.1186/1758-5996-2-19 20331871
3. Metabolic syndrome and cardiovascular disease in south Asians. Eapen D, Kalra GL, Merchant N, Arora A, Khan BV, Vasc Health Risk Manag 2009 5 731 743 19756165
4. South Asians and cardiovascular risk: what clinicians should know. Gupta M, Singh N, Verma S, Circulation 2006 113 924 e929 10.1161/CIRCULATIONAHA.105. 583815 16801466 (Pubitemid 44297217)
5. The metabolic syndrome in South Asians: continuing escalation and possible solutions. Misra A, Misra R, Wijesuriya M, Banerjee D, Indian J Med Res 2007 125 345 354 17496360 (Pubitemid 46805451)
6. The metabolic syndrome in developing countries. Mohan V, Deepa M, Diabetes Voice 2006 51 15 17
7. Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Rahim MA, Hussain A, Khan AKA, Sayeed MA, Keramat Ali SM, Vaaler S, Diabetes Res Clin Pract 2007 77 300 305 10.1016/j.diabres.2006.11.010 17187890 (Pubitemid 46671652)
8. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
9. The IDF Consensus Worldwide Definition of the Metabolic Syndrome, International Diabetes Federation. 2005 [updated 2006; cited 2007 November 15]; available from: [ http://www.idf.org/webdata/docs/MetS-def-update2006.pdf
10. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
11. The social environment and health: a discussion of the epidemiologic literature. Yen IH, Syme SL, Annu Rev Public Health 1999 20 287 308 10.1146/annurev.publhealth.20.1.287 10352860 (Pubitemid 29242581)
12. Socioeconomic status and risk for arsenic-related skin lesions in Bangladesh. Argos M, Parvez F, Chen Y, Hussain AZ, Momotaj H, Howe GR, Graziano JH, Ahsan H, Am J Public Health 2007 97 825 831 10.2105/AJPH.2005.078816 17395836 (Pubitemid 47280127)
13. Measures of socioeconomic status for child health research: comparative results from Bangladesh and Pakistan. Durkin MS, Islam S, Hasan ZM, Zaman SS, Soc Sci Med 1994 38 1289 1297 10.1016/0277-9536(94)90192-9 8016692 (Pubitemid 24109624)
14. Rural urban differences of cardiovascular disease risk factors in adult Asian Indians. Das M, Pal S, Ghosh A, Am J Hum Biol 2008 20 440 445 10.1002/ajhb.20757 18348170
15. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Ford ES, Giles WH, Dietz WH, JAMA 2002 287 356 359 10.1001/jama.287.3.356 11790215 (Pubitemid 34251969)
16. Prevalence of the metabolic syndrome among Omani adults. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P, Diabetes Care 2003 26 1781 1785 10.2337/diacare.26.6.1781 12766109 (Pubitemid 36929119)
17. Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S, Diabetes Res Clin Pract 2003 61 29 37 10.1016/S0168-8227(03)00066-4 12849921 (Pubitemid 36808841)
18. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB, Arch Intern Med 2003 163 427 436 10.1001/archinte.163.4.427 12588201 (Pubitemid 36241019)
19. Prevalence of the metabolic syndrome in middle-aged men and women. Villegas R, Perry IJ, Creagh D, Hinchion R, O'Halloran D, Diabetes Care 2003 26 3198 3199 10.2337/diacare.26.11.3198 14578276
20. Increasing prevalence of the metabolic syndrome among US adults. Ford ES, Giles WH, Mokdad AH, Diabetes Care 2004 27 2444 2449 10.2337/diacare.27.10.2444 15451914 (Pubitemid 39281399)
21. Prevalence of metabolic syndrome in an Indian urban population. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K, Int J Cardiol 2004 97 257 261 10.1016/j.ijcard.2003.11.003 15458693 (Pubitemid 39286845)
22. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non diabetic European men and women. DECODE Study Group, Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, Arch Intern Med 2004 164 1066 1076 10.1001/archinte.164.10.1066 15159263 (Pubitemid 38668985)
23. Finnish Diabetes Prevention Study Group Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Ilanne-Parikka P, Eriksson JG, Lindström J, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, et al. Diabetes Care 2004 27 2135 2140 10.2337/diacare.27.9.2135 15333474 (Pubitemid 39167175)
24. Greenland Population Study Prevalence of the metabolic syndrome among the Inuit in Greenland: a comparison between two proposed definitions. Jørgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K, Diabet Med 2004 21 1237 1242 10.1111/j.1464-5491.2004.01294.x 15498091 (Pubitemid 39472380)
25. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, Gill T, Ruffin R, Diabetes Care 2005 28 2777 2779 10.2337/diacare.28.11.2777 16249557 (Pubitemid 43951176)
26. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP, Curr Med Res Opin 2005 21 1157 1159 10.1185/030079905X53333 16083523 (Pubitemid 41140717)
27. NávoaFJ: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fabregas M, Diabet Med 2005 22 1751 1756 10.1111/j.1464-5491.2005.01745.x 16401323 (Pubitemid 43046479)
28. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Ford ES, Diabetes Care 2005 28 2745 2749 10.2337/diacare.28.11.2745 16249550 (Pubitemid 43951170)
29. Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M, Hypertens Res 2005 28 27 34 10.1291/hypres.28.27 15969252 (Pubitemid 40584960)
30. The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. Lorenzo C, Williams K, Gonzalez-Villalpando C, Haffner SM, Diabetes Care 2005 28 2480 2485 10.2337/diacare.28.10.2480 16186283 (Pubitemid 41384297)
31. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee, Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH, Diabetes Res Clin Pract 2005 67 251 257 10.1016/j.diabres.2004.07.022 15713358 (Pubitemid 40254315)
32. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li X, Hu FB, J Am Coll Cardiol 2006 47 1588 1594 10.1016/j.jacc.2005. 11.074 16630995
33. Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing. Li ZY, Xu GB, Xia TA, Atherosclerosis 2006 184 188 192 10.1016/j.atherosclerosis.2005.03.033 15927187 (Pubitemid 41721087)
34. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M, BMC Public Health 2006 6 92 10.1186/1471-2458-6-92 16606462
35. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Deepa M, Farooq S, Datta M, Deepa R, Mohan V, Diabetes Metab Res Rev 2007 23 127 134 10.1002/dmrr.658 16752431
36. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N, Int J Obes Relat Metab Disord 2001 25 1722 1729 10.1038/sj.ijo.0801748 11753596 (Pubitemid 33052085)
37. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Lancet 2007 370 1829 1839 18061058
38. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Linsel-Nitschke P, Tall AR, Nat Rev Drug Discov 2005 4 193 205 10.1038/nrd1658 15738977 (Pubitemid 40372554)
39. Differential diagnosis of familial high density lipoprotein deficiency syndromes. Von Eckardstein A, Atherosclerosis 2006 186 231 239 10.1016/j.atherosclerosis.2005.10.033 16343506
40. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F, Exp Gerontol 2009 44 136 160 10.1016/j.exger.2008.11.003 19041386
41. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the middle east. The national survey of risk factors for non communicable disease of Iran. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R, Diabetes Care 2009 32 1092 1097 10.2337/dc08-1800 19279302
42. The value of HDL genetics. Holleboom AG, Vergeer M, Hovingh GK, et al. Curr Opin Lipidol 2008 19 385 394 10.1097/MOL.0b013e328306a043 18607186
43. Non-biochemical risk factors for cardiovascular disease in general clinic-based rural population of Bangladesh. Zaman MM, Choudhury SR, Ahmed J, Numan SM, Islam MS, Yoshiike N, J Epidemiol 2004 14 63 68 10.2188/jea.14.63 15162980 (Pubitemid 41403898)
44. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, Thakur JS, et al. Diabetes Res Clin Pract 2010 89 181 188 10.1016/j.diabres. 2010.03.010 20381187
45. Intra-urban differences in the prevalence of the metabolic syndrome in southern India - the Chennai Urban Population Study (CUPS No. 4). Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R, Diabet Med 2001 18 280 287 10.1046/j.1464-5491.2001.00421.x 11437858 (Pubitemid 32579357)
46. Development of carbohydrate intolerance in offspring of Asian Indian conjugal type 2 diabetic parents. Ramachandran A, Snehalatha C, Mohan V, Viswanathan M, Diabetes Res Clin Pract 1990 8 269 273 10.1016/0168-8227(90) 90126-E 2187663 (Pubitemid 20111452)
47. Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes. Srinivasan SR, Frontini MG, Berenson GS, Metabolism 2003 52 443 450 10.1053/meta.2003.50065 12701056 (Pubitemid 36773266)
48. Parental history of type 2 diabetes mellitus, metabolic syndrome and cardiometabolic risk factors in Asian Indian adolescents. Anjana RM, Lakshminarayanan S, Deepa M, Farooq S, Pradeepa R, Mohan V, Metabolism 2009 58 344 350 10.1016/j.metabol.2008.10.006 19217449
49. Metabolic syndrome in rural Bangladesh: Comparison of newly proposed IDF, modified ATP III and WHO criteria and their agreements. Rahim MA, Azad Khan AK, Sayeed MA, Akhtar B, Nahar Q, Ali SMK, Hussain A, Diabetes Metab Syndr Clin Res Rev 2007 1 251 257 10.1016/j.dsx.2007.09.006 (Pubitemid 350000980)
50. Obesity and the metabolic syndrome in developing countries. Misra A, Khurana L, J Clin Endocrinol Metab 2008 93 9 S30 10.1210/jc.2008-1595 18987276
51. Heterogeneity of coronary heart risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG, et al. Br Med J 1999 319 215 220 10.1136/bmj.319.7204.215 (Pubitemid 29338688)
52. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Eriksson KF, Lindgärde F, Diabetologia 1991 34 891 898 10.1007/BF00400196 1778354
53. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, et al. Diabetes Care 1997 20 537 544 10.2337/diacare.20.4.537 9096977
54. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. Finnish Diabetes Prevention Study Group, Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. N Engl J Med 2001 344 1343 1350 10.1056/NEJM200105033441801 11333990 (Pubitemid 32378388)